Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2018. Start Trial.
Date Value
October 27, 2026 4.349B
October 26, 2026 4.349B
October 23, 2026 4.349B
October 22, 2026 4.349B
October 21, 2026 4.349B
October 20, 2026 4.349B
October 19, 2026 4.786B
October 16, 2026 4.786B
October 15, 2026 4.786B
October 14, 2026 4.786B
October 13, 2026 4.786B
October 12, 2026 4.786B
October 09, 2026 5.412B
October 08, 2026 5.412B
October 07, 2026 5.412B
October 06, 2026 5.412B
October 05, 2026 5.412B
October 02, 2026 5.412B
October 01, 2026 5.412B
September 30, 2026 5.412B
September 29, 2026 5.412B
September 28, 2026 5.412B
September 25, 2026 5.412B
September 24, 2026 5.412B
September 23, 2026 5.412B
Date Value
September 22, 2026 5.412B
September 21, 2026 5.412B
September 18, 2026 5.412B
September 17, 2026 5.412B
September 16, 2026 5.412B
September 15, 2026 5.412B
September 14, 2026 5.412B
September 11, 2026 5.412B
September 10, 2026 5.412B
September 09, 2026 5.412B
September 08, 2026 5.412B
September 04, 2026 5.412B
September 03, 2026 5.412B
September 02, 2026 5.412B
September 01, 2026 5.412B
August 31, 2026 5.412B
August 28, 2026 5.412B
August 27, 2026 5.412B
August 26, 2026 5.412B
August 25, 2026 5.412B
August 24, 2026 5.412B
August 21, 2026 5.412B
August 20, 2026 5.412B
August 19, 2026 5.412B
August 18, 2026 5.412B

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Ascletis Pharma, Inc. 667.59M
CStone Pharmaceuticals Co. Ltd. 974.27M
RemeGen Co., Ltd. 4.874B
InnoCare Pharma Ltd. 1.921B
Adagene, Inc. 260.51M

Enterprise Value Related Metrics